Search for: "Health One Medical Center v. Bristol-Myers Squibb Co."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
23 Jun 2011, 6:33 pm
IMS Health, as a co-author of an amicus brief, a Pharma FaceOff panelist, and a blogger. [read post]
19 May 2013, 9:12 am
Bristol-Myers Squibb Co., No. [read post]
3 Mar 2012, 5:36 pm
Bristol-Myers Squibb Co., 1998 WL 812318 (M.D. [read post]
15 Apr 2011, 6:02 am
Bristol-Myers Squibb, 1998 WL 812318, at *46 (M.D. [read post]
2 Jun 2011, 12:46 pm
Michael Reese Hospital & Medical Center, 513 N.E.2d 387, 393 (Ill. 1987). [read post]
3 Feb 2011, 2:11 pm
Bristol-Myers Squibb Co., 121 F. [read post]
21 Jun 2012, 7:40 am
Bristol-Myers Squibb Co., 2009 WL 5216982, at *5-6 (D.N.J. [read post]
25 Apr 2015, 11:03 am
Considering the intellectual vacuum the Center had to fill, and the speed with which it had to work, the first edition was a stunning accomplishment. [read post]
18 Mar 2011, 10:04 am
Bristol-Myers Squibb Co., 1998 WL 812318 (M.D. [read post]
18 Jul 2014, 11:55 am
Fifth Avenue Chrysler Center, Inc,, 454 P.2d 244, 247 (Alaska 1969).ArizonaNo Arizona court has directly passed on innovator liability, but the federal district court in the Darvocetlitigation twice held that the theory was incompatible with Arizona law. [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 Mar 2012, 6:52 am
Bristol-Myers Squibb (?) [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
